These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4139860)

  • 1. The quest for a short-acting nondepolarizing neuromuscular blocking agent.
    Savarese JJ; Kitz RJ
    Acta Anaesthesiol Scand Suppl; 1973; 53():43-58. PubMed ID: 4139860
    [No Abstract]   [Full Text] [Related]  

  • 2. THE EFFECTS OF HEXAFLUORENIUM AND EDROPHONIUM ON THE NEUROMUSCULAR BLOCKING ACTIONS OF SUCCINYLCHOLINE, DECAMETHONIUM, IMBRETIL AND D-TUBOCURARINE.
    KATZ RL; GISSEN AJ; KARIS JH
    Anesthesiology; 1965; 26():154-61. PubMed ID: 14261050
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacology of new short-acting nondepolarizing ester neuromuscular blocking agents: clinical implications.
    Savarese JJ; Ginsburg S; Lee SM; Kitz RJ
    Anesth Analg; 1973; 52(6):982-8. PubMed ID: 4271295
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of the neuromuscular blocking and autonomic effects of two new short-acting muscle relaxants with those of succinylcholine in the anesthetized cat and pig.
    Muir AW; Houston J; Marshall RJ; Bowman WC; Marshall IG
    Anesthesiology; 1989 Mar; 70(3):533-40. PubMed ID: 2564263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of neuromuscular blocking agents.
    Fisher DM
    Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S4-9. PubMed ID: 10437710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between the effects of edrophonium and choline in the skeletal muscles of the cat.
    BLABER LC; BOWMAN WC
    Br J Pharmacol Chemother; 1959 Dec; 14(4):456-66. PubMed ID: 13801135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of histamine-N-methyltransferase activity by neuromuscular blocking drugs.
    Harle DG; Baldo BA; Fisher MM
    Agents Actions; 1985 Oct; 17(1):27-31. PubMed ID: 4083176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular blocking agents: structure and activity.
    Pauling P; Petcher TJ
    Chem Biol Interact; 1973 Jun; 6(6):351-65. PubMed ID: 4270640
    [No Abstract]   [Full Text] [Related]  

  • 9. SOME EFFECTS OF ALTERING ONIUM SUBSTITUENTS ON THE INTERNITROGEN DISTANCE IN GANGLIONIC AND NEUROMUSCULAR BLOCKING AGENTS.
    ELWORTHY PH
    J Pharm Pharmacol; 1964 Jun; 16():375-80. PubMed ID: 14200397
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON THE EFFECT OF CURARIFORM DRUGS ON THE GLOSSO-MAXILLARY REFLEX].
    MURATOV VK
    Farmakol Toksikol; 1963; 26():597-602. PubMed ID: 14123760
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuromuscular blocking agents. Replacement of quaternary ammonium groups in bis-onium compounds by amidinium, guanidinium, thiouronium, sulphonium and sulphoxonium groups.
    Bamford DG; Biggs DF; Chaplen P; Davis M
    J Pharm Pharmacol; 1970 Feb; 22(2):110-5. PubMed ID: 4392244
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of the neuromuscular blocking drugs alcuronium, decamethonium, gallamine, pancuronium, ritebronium, tercuronium and d-tubocurarine with muscarinic acetylcholine receptors in the heart and ileum.
    Nedoma J; Dorofeeva NA; Tucek S; Shelkovnikov SA; Danilov AF
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):176-81. PubMed ID: 4010794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium carbonate and neuromuscular blocking agents.
    Hill GE; Wong KC; Hodges MR
    Anesthesiology; 1977 Feb; 46(2):122-6. PubMed ID: 835845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of hypercarbia on the activity of neuromuscular blocking agents in the cat.
    JOHANSEN SH; OSGOOD PF
    Acta Pharmacol Toxicol (Copenh); 1962; 19():212-8. PubMed ID: 13957827
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential clinical uses of short-acting nondepolarizing neuromuscular-blocking agents as predicted from animal experiments.
    Savarese JJ; Antonio RP; Ginsburg S
    Anesth Analg; 1975; 54(5):669-78. PubMed ID: 126651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of the neuromuscular blocking agents.
    Larijani GE; Gratz I; Silverberg M; Jacobi AG
    DICP; 1991 Jan; 25(1):54-64. PubMed ID: 1672571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A philosophy of relaxation. Eleventh annual Baxter-Travenol lecture.
    Churchill-Davidson HC
    Anesth Analg; 1973; 52(4):495-501. PubMed ID: 4352148
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology and use of muscle relaxants in infants and children.
    Nugent SK; Laravuso R; Rogers MC
    J Pediatr; 1979 Mar; 94(3):481-7. PubMed ID: 423041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of ultra short-acting muscle relaxant agents: history, research strategies, and challenges.
    Gyermek L
    Med Res Rev; 2005 Nov; 25(6):610-54. PubMed ID: 16086361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel monoquaternary neuromuscular blocking agent.
    Bamford DG; Biggs DF; Chaplen P; Davis M; Maconochie J
    Experientia; 1972 Sep; 28(9):1069-70. PubMed ID: 4198706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.